Webcast/CME - Infectious Complications of Biologic Therapies: Preventive and Therapeutic Strategies

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Mycoses

EXPLORE :

Most Read News

All Webcasts / CME

Warning | Privacy

Recent webcasts/CME - Mycoses

	Prophylaxis and Management of Invasive Fungal Infections in Older Patients with Acute Myelogenous Leukemia
	Fibrosing Mediastinitis: Causes, Diagnosis, and Treatment
	Management of Cryptococcal Meningitis in the Antiretroviral Therapy Era: More than Just Antifungals
	Pulmonary Complications of Anti-Tumor Necrosis Factor-a Therapy

Recent news - Mycoses

	Blood Flow Cytometry May Be Preferable Way to Diagnose, Analyse Mycosis Fungoides: Presented at ASCP - (DGDispatch)
	A homozygous CARD9 mutation in a family with susceptibility to fungal infections - (N Engl J Med)
	Human dectin-1 deficiency and mucocutaneous fungal infections - (N Engl J Med)
	Topical Onychomycosis Treatment More Effective Than Oral Treatment : Presented at EADV - (DGDispatch)
	Central Nervous System Fungal Infections Respond to Real-World Voriconazole Therapy: Presented at ICAAC - (DGDispatch)

Recent cases - Mycoses

	Pulmonary Coccidioidomycosis: Import Illness And The Importance Of Travel History
	Diagnosis Of Invasive Aspergillus Tracheobronchitis Facilitated By Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: A Case Report
	A 19-Year-Old Man with Progressive Lung Infiltrates
	Newly Formed Cystic Lesions for the Development of Pneumomediastinum in Pneumocystis Jirovecii Pneumonia
	Ulcerative Leg Nodules in a Transplant Recipient

personal edition > mycoses > webcasts/CME

Webcasts/CME

E-Mail this webcast/CME to a colleague

Infectious Complications of Biologic Therapies: Preventive and Therapeutic Strategies

Presented by:	The Cleveland Clinic Foundation Center for Continuing Education
Lecturer	Kevin L. Winthrop, MD, MPH
Approximate duration:	30 mins.
Summary points:	This audiovisual program discusses the importance of assessing patient immunocompetence; the long-term relative risks of serious bacterial and opportunistic infections among biologic agents; the effects of biologic agents on humoural immunity, immunoglobulins, and vaccine response, as well as strategies for prevention and treatment of infectious complications in patients receiving biologic therapies.
Accreditation:	The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s). Expiration Date: February 5, 2010.
Other:

Additional Information